RFS
JUNO

Rockefeller Financial Services’s Juno Therapeutics, Inc. JUNO Stock Holding History

Rockefeller Financial Services’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$110K Sell
2,407
-226
-9% -$11.3K ﹤0.01% 377
2017
Q3 		$118K Sell
2,633
-655
-20% -$22.3K ﹤0.01% 373
2017
Q2 		$98K Sell
3,288
-226
-6% -$5.58K ﹤0.01% 341
2017
Q1 		$78K Buy
3,514
+49
+1% +$1.05K ﹤0.01% 376
2016
Q4 		$65K Hold
3,465
– – ﹤0.01% 406
2016
Q3 		$104K Buy
3,465
+3,239
+1,433% +$101K ﹤0.01% 348
2016
Q2 		$9K Hold
226
– – ﹤0.01% 443
2016
Q1 		$9K Hold
226
– – ﹤0.01% 532
2015
Q4 		$10K Hold
226
– – ﹤0.01% 497
2015
Q3 		$9K Hold
226
– – ﹤0.01% 483
2015
Q2 		$12K Buy
+226
New +$12K ﹤0.01% 429

Other funds holding JUNO

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Rockefeller Financial Services's JUNO Position: Q4 2017 in Review

Rockefeller Financial Services reduced its Juno Therapeutics, Inc. (JUNO) stake by 8.6% in Q4 2017, selling an estimated $11.3K and leaving 2,407 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #377.

Rockefeller Financial Services first reported a position in JUNO in Q2 2015 and has held it in 11 quarters since. The position peaked at $118K in Q3 2017. 237 funds tracked by Wall St. Rank hold JUNO as of Q4 2017.

  • Rockefeller Financial Services held 2,407 shares of Juno Therapeutics, Inc. worth $110K as of Q4 2017.
  • Rockefeller Financial Services sold 226 Juno Therapeutics, Inc. shares in Q4 2017, an estimated $11.3K.
  • Juno Therapeutics, Inc. made up ﹤0.01% of Rockefeller Financial Services's portfolio in Q4 2017, its #377 holding.
  • Rockefeller Financial Services first reported a position in Juno Therapeutics, Inc. in Q2 2015 and has held it in 11 quarters since.
  • Rockefeller Financial Services's Juno Therapeutics, Inc. position peaked at $118K in Q3 2017.
  • 237 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2017.

Based on Rockefeller Financial Services's 13F filing for Q4 2017, filed 2 Feb 2018.